Superior Planning LLC’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
Other funds holding PTGX
Superior Planning LLC's PTGX Position: Q3 2026 in Review
Superior Planning LLC opened a new position in Protagonist Therapeutics (PTGX) in Q3 2026: 207 shares worth $29.2K. The stake represents 0.01% of the portfolio and ranks #548 among its holdings.
307 funds tracked by Wall St. Rank hold PTGX as of Q3 2026.
- Superior Planning LLC held 207 shares of Protagonist Therapeutics worth $29.2K as of Q3 2026.
- Protagonist Therapeutics was a new Superior Planning LLC position in Q3 2026.
- Protagonist Therapeutics made up 0.01% of Superior Planning LLC's portfolio in Q3 2026, its #548 holding.
- 307 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q3 2026.
Based on Superior Planning LLC's 13F filing for Q3 2026, filed 12 Nov 2026.